Celldex Therapeutics, Inc. (CLDX) SEC Filings — 2025
11 SEC filings for Celldex Therapeutics, Inc. (CLDX) in 2025.
Filings
- Celldex Losses Widen on Soaring R&D for Barzolvolimab — 10-Q · Nov 10, 2025
- Celldex Therapeutics, Inc. 8-K Filing — 8-K · Nov 10, 2025
- Celldex Therapeutics Files 8-K — 8-K · Aug 19, 2025
- Celldex Cuts R&D Spend Amidst Continued Net Losses — 10-Q · Aug 7, 2025
- Celldex Therapeutics Files 8-K on Financials — 8-K · Aug 7, 2025
- Celldex Therapeutics Files 8-K on Director Changes and Shareholder Votes — 8-K · Jun 6, 2025
- Celldex Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Celldex Therapeutics Files 8-K on Financials — 8-K · May 8, 2025
- Celldex Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 21, 2025
- Celldex Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Celldex Therapeutics Files 8-K on Financials — 8-K · Feb 27, 2025